Edge Wealth Management LLC Biomarin Pharmaceutical Inc Transaction History

Edge Wealth Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$74.28 - $92.69 $1,411 - $1,761	-19 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$71.72 - $91.47 $1,864 - $2,378	-26 Reduced 57.78%	19 $2,000
Q4 2021 Jan 14, 2022	BUY	$71.72 - $91.47 $1,864 - $2,378	26 Added 136.84%	45 $2,000
Q3 2021 Oct 13, 2021	BUY	$74.77 - $85.47 $1,420 - $1,623	19 New	19 $1,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Edge Wealth Management LLC with notifications on news.